Regal Investment Advisors LLC reduced its stake in CME Group Inc. (NASDAQ:CME – Get Rating) by 15.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 4,936 shares of the financial services provider’s stock after selling 935 shares during the quarter. Regal Investment Advisors LLC’s holdings in CME Group were worth $1,128,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently bought and sold shares of CME. Parnassus Investments LLC increased its position in shares of CME Group by 15.5% during the third quarter. Parnassus Investments LLC now owns 7,097,398 shares of the financial services provider’s stock valued at $1,372,495,000 after purchasing an additional 951,681 shares during the period. Bank of New York Mellon Corp boosted its stake in CME Group by 2.5% in the third quarter. Bank of New York Mellon Corp now owns 6,790,837 shares of the financial services provider’s stock worth $1,313,212,000 after purchasing an additional 164,311 shares in the last quarter. Geode Capital Management LLC boosted its stake in CME Group by 2.6% in the third quarter. Geode Capital Management LLC now owns 6,208,020 shares of the financial services provider’s stock worth $1,197,699,000 after purchasing an additional 158,652 shares in the last quarter. Vontobel Asset Management Inc. boosted its stake in CME Group by 1.5% in the third quarter. Vontobel Asset Management Inc. now owns 4,067,692 shares of the financial services provider’s stock worth $818,075,000 after purchasing an additional 59,267 shares in the last quarter. Finally, FIL Ltd boosted its stake in CME Group by 4.3% in the third quarter. FIL Ltd now owns 3,206,730 shares of the financial services provider’s stock worth $620,118,000 after purchasing an additional 132,681 shares in the last quarter. Hedge funds and other institutional investors own 86.71% of the company’s stock.
In other CME Group news, insider Hilda Harris Piell sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 3rd. The stock was sold at an average price of $244.00, for a total transaction of $488,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sunil Cutinho sold 4,900 shares of the company’s stock in a transaction that occurred on Monday, February 14th. The shares were sold at an average price of $237.96, for a total value of $1,166,004.00. The disclosure for this sale can be found here. Insiders sold a total of 16,150 shares of company stock valued at $3,786,944 over the last ninety days. 0.30% of the stock is currently owned by corporate insiders.
CME Group (NASDAQ:CME – Get Rating) last announced its quarterly earnings data on Wednesday, April 27th. The financial services provider reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.00 by $0.11. CME Group had a return on equity of 9.29% and a net margin of 57.98%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the business earned $1.79 EPS. The firm’s revenue was up 7.4% compared to the same quarter last year. As a group, research analysts anticipate that CME Group Inc. will post 7.9 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, June 27th. Investors of record on Friday, June 10th will be given a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date of this dividend is Thursday, June 9th. CME Group’s payout ratio is 52.22%.
Several brokerages have recently issued reports on CME. StockNews.com started coverage on CME Group in a research note on Thursday, March 31st. They set a “hold” rating on the stock. JPMorgan Chase & Co. lowered their price target on CME Group from $202.00 to $201.00 and set a “neutral” rating for the company in a report on Thursday, February 10th. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $235.00 to $260.00 and gave the stock a “hold” rating in a report on Thursday, February 10th. Credit Suisse Group decreased their price objective on CME Group from $265.00 to $262.00 and set a “neutral” rating for the company in a report on Tuesday, April 5th. Finally, Rosenblatt Securities decreased their price objective on CME Group from $268.00 to $267.00 and set a “neutral” rating for the company in a report on Thursday, April 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company. According to MarketBeat, CME Group presently has an average rating of “Hold” and an average target price of $254.75.
About CME Group (Get Rating)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
- Get a free copy of the StockNews.com research report on CME Group (CME)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.